Phytochemical Investigation of Eleusine Indica for In-Vivo Anti-Hypertensive Activity


Authors : A. V. Desai, V. M. Patil, S. S. Patil, V. A. Kangralkar,

Volume/Issue : Volume 2 - 2017, Issue 6 - June

Google Scholar : https://goo.gl/WYVGDo

Scribd : https://goo.gl/CZVxmN

Thomson Reuters ResearcherID : https://goo.gl/3bkzwv

: Eleusine indica L. Gaertn also known as wire grass belonging to family poaceae. The plant is used for deforming, eliminate or reduce cough and lung troubles, dysentery, heart problems and high blood pressure, spleen and liver complaints, bladder and kidney stone and in case of sprains, dislocation of bones and lumbago. The plant contains cyan genetic glycoside, albuminoids, starch, fatty oils, phenol compounds and flavonoids. The present investigation was carried out to isolate, purify and characterize active constituents from the whole plant of Eleusine indica L. Gaertn. Powdered material of whole plant of Eleusine indica L. Gaertn was taken for the preparation of extracts using soxhlet apparatus. The various photochemical tests were performed for alkaloids, glycosides, phenol, flavonoids etc. TLC and HPTLC were done for isolation of compounds. The isolated compounds were further characterized by FTIR, Ultraviolet spectroscopy and GC-MS. The anti-hypertensive activity was evaluated by using in-vivo model.The ethanolic extract of Eleusine indica L. Gaertn significantly inhibited the hypertension. Thus ethanolic extract of whole plant of Eleusine indica L. Gaertnhave significant anti-hypertensive activity.

Keywords : Eleusine indica L. Gaertn, Poaceae, HPTLC, FTIR, GC-MS, anti-hypertensive activity.

CALL FOR PAPERS


Paper Submission Last Date
31 - July - 2021

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe